Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions
NY Attorney General secures $523 million settlement from opioid manufa
Teva refiles long-acting schizophrenia drug after FDA rejection
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Pharmaceuticals USA closing Haverstraw plant
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
NY Jury Finds Teva Fueled Opioid Addiction In Empire State - Haute Lawyer by Haute Living
New York reaches $523 million opioid settlement with drug manufacturer Teva | The Hill
Teva to pay up to $523 million to New York state to settle opioid suit | Business Insurance
Drugmaker Teva Misled Court to Dodge Opioid Trial, New York State Claims - Bloomberg
NY and Teva Reach $523M Opioid Settlement - The National Trial Lawyers
New York Jury Holds Drugmaker Teva Liable in Opioid Crisis
NYS Attorney General James Secures $523 Million from Teva Pharmaceuticals for Role in Opioid Crisis
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva again in the sights of New York Attorney General over alleged role in opioid crisis | Seeking Alpha
Opioid manufacturer Teva Pharmaceuticals announces $523M settlement with New York state - JURIST - News
New York, NY + REI - Soho Flagship - Curbside Available + Teva + Sandals - Products
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
